Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nevus, Sebaceous of Jadassohn × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 33 Depression 23 Fatigue 21 Prostatic Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Multiple Myeloma 13 Lymphoma, Follicular 13 Carcinoma, Non-Small-Cell Lung 12 Pain 11 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, B-Cell, Marginal Zone 10 Lung Neoplasms 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Colorectal Neoplasms 10 Burkitt Lymphoma 10 Anxiety Disorders 10 Lymphoma, Large-Cell, Immunoblastic 9 Vomiting 8 Nausea 8 Leukemia, Myeloid, Chronic-Phase 8 Leukemia, Myeloid, Acute 8 Hodgkin Disease 8 Blast Crisis 8 Lymphoma, T-Cell, Cutaneous 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia, Hairy Cell 7 Carcinoma, Ovarian Epithelial 7

Interventions

burosumab 4 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04320316 2022-10-07

ENS

University of Alabama at Birmingham

Phase 4 Completed

1 enrolled 10 charts

Nevus, Sebaceous of Jadassohn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡